← Feed

$ABCL

2 theses
bullish 100%neutral 0%bearish 0%
Avg return (1w)
—
Win rate (1w)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices delayed ~15 min · refreshed just now
$ABCLSEC Form 4bullish
Booth Andrew · Chief Financial Officer at AbCellera Biologics Inc. · 3h agono track record yet
Long 37,200 shares of ABCL
Bought 37,200 @ $10.32 avg · $383,904 · 2026-08-14

Form 4: Booth Andrew bought ABCL

Booth Andrew (Chief Financial Officer at AbCellera Biologics Inc.) reported an open-market purchase of 37,200 shares of ABCL at an average $10.32, roughly $383,904, in a Form 4 filed 2026-08-14.

Now $11.42just now
View filing on SEC.gov →
$ABCLSEC Form 4bullish
Hayden Michael R · AbCellera Biologics Inc. · 4h agono track record yet
Long 46,387 shares of ABCL
Bought 46,387 @ $10.37 avg · $481,033 · 2026-08-12

Form 4: Hayden Michael R bought ABCL

Hayden Michael R (Director at AbCellera Biologics Inc.) reported an open-market purchase of 46,387 shares of ABCL at an average $10.37, roughly $481,033, in a Form 4 filed 2026-08-14.

Now $11.42just now
View filing on SEC.gov →

End of results.